1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
However, the drugmaker has since seen its shares decline substantially due to several factors, most notably headwinds related to one of its key growth drivers (more on that later). Still, many analysts on Wall Street think the correction is way overdone. Regeneron's stock could soar by 50% in the next year from its current levels if we go by its average price target of $1,053 (according to Yahoo! Finance). Should investors rush to buy Regeneron's shares? The Eylea problem Regeneron has largely relied on two main products to drive top-line growth in recent years. One is Dupixent, an eczema treatment whose rights it shares with Sanofi , based in France. The other is Eylea, a medicine for wet age-related macular degeneration (an eye disease) that it comarkets with Bayer However, Eylea has been facing serious issues in the past two years. It first dealt with stiff competition from Roche 's Vabysmo. Regeneron did find a solution, at least somewhat, for Vabysmo's challenge. It devel
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- The First Human Bird Flu Death Has Occurred in the United States [CNET News]CNET News
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer [Yahoo! Finance]Yahoo! Finance
- These CEO's reveal their top festive reads for the year [Fortune]Fortune
- Olympian Jordan Chiles is setting her sights on a new goal: raising awareness of type 1 diabetes [Fortune]Fortune
- Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 12/23/24 - Form 6-K
- 12/20/24 - Form 6-K
- 12/13/24 - Form 6-K
- SNY's page on the SEC website